Compare KRMD & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRMD | SENS |
|---|---|---|
| Founded | 1980 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.3M | 252.5M |
| IPO Year | N/A | N/A |
| Metric | KRMD | SENS |
|---|---|---|
| Price | $6.34 | $6.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $5.88 | ★ $25.58 |
| AVG Volume (30 Days) | 215.8K | ★ 362.4K |
| Earning Date | 11-12-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $39,070,637.00 | $29,298,000.00 |
| Revenue This Year | $23.36 | $59.55 |
| Revenue Next Year | $18.63 | $70.49 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 22.12 | ★ 31.94 |
| 52 Week Low | $1.86 | $5.25 |
| 52 Week High | $6.61 | $28.00 |
| Indicator | KRMD | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 66.31 | 48.13 |
| Support Level | $5.48 | $6.03 |
| Resistance Level | $6.61 | $6.44 |
| Average True Range (ATR) | 0.34 | 0.35 |
| MACD | 0.01 | -0.13 |
| Stochastic Oscillator | 70.40 | 17.91 |
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.